129 related articles for article (PubMed ID: 15041467)
1. Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone.
Liu X; Zhou B; Xue L; Qiu W; Shih J; Zheng S; Yen Y
Biochem Pharmacol; 2004 Apr; 67(8):1499-511. PubMed ID: 15041467
[TBL] [Abstract][Full Text] [Related]
2. Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance.
Zhou B; Mo X; Liu X; Qiu W; Yen Y
Cytogenet Cell Genet; 2001; 95(1-2):34-42. PubMed ID: 11978967
[TBL] [Abstract][Full Text] [Related]
3. An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone.
Liu X; Zhou B; Mi S; Xue L; Shih J; Lee J; Chau J; Un F; Yen Y
Biochem Pharmacol; 2007 Jun; 73(12):1927-38. PubMed ID: 17428446
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line.
Goan YG; Zhou B; Hu E; Mi S; Yen Y
Cancer Res; 1999 Sep; 59(17):4204-7. PubMed ID: 10485455
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.
Tu M; Li H; Lv N; Xi C; Lu Z; Wei J; Chen J; Guo F; Jiang K; Song G; Gao W; Miao Y
Mol Cancer; 2017 Mar; 16(1):66. PubMed ID: 28327155
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines].
Liu XQ; Wang WX; Lin L; Song ST
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):17-21. PubMed ID: 20211060
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone.
Chung V; Zhou B; Liu X; Zhu L; Boo LM; Nguyen HV; Ann DK; Song J; Chen Y; Yen Y
Mol Cancer Ther; 2006 Mar; 5(3):533-40. PubMed ID: 16546967
[TBL] [Abstract][Full Text] [Related]
8. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
10. Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells.
Zhou B; Mi S; Mo X; Shih J; Tsai J; Hu E; Hsu M; Kay K; Yen Y
Anticancer Res; 2002; 22(3):1369-77. PubMed ID: 12168813
[TBL] [Abstract][Full Text] [Related]
11. An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines.
Davidson JD; Ma L; Flagella M; Geeganage S; Gelbert LM; Slapak CA
Cancer Res; 2004 Jun; 64(11):3761-6. PubMed ID: 15172981
[TBL] [Abstract][Full Text] [Related]
12. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y.
Hirose T; Sowa Y; Takahashi S; Saito S; Yasuda C; Shindo N; Furuichi K; Sakai T
Oncogene; 2003 Oct; 22(49):7762-73. PubMed ID: 14586402
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
[TBL] [Abstract][Full Text] [Related]
15. RNF4 is a coactivator for nuclear factor Y on GTP cyclohydrolase I proximal promoter.
Wu SM; Kuo WC; Hwu WL; Hwa KY; Mantovani R; Lee YM
Mol Pharmacol; 2004 Nov; 66(5):1317-24. PubMed ID: 15496512
[TBL] [Abstract][Full Text] [Related]
16. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
Rundall BK; Denlinger CE; Jones DR
Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human alpha 1(XI) collagen gene (COL11A1).
Matsuo N; Yu-Hua W; Sumiyoshi H; Sakata-Takatani K; Nagato H; Sakai K; Sakurai M; Yoshioka H
J Biol Chem; 2003 Aug; 278(35):32763-70. PubMed ID: 12805369
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human mitochondrial thiamine pyrophosphate transporter SLC25A19 minimal promoter: a role for NF-Y in regulating basal transcription.
Nabokina SM; Valle JE; Said HM
Gene; 2013 Oct; 528(2):248-55. PubMed ID: 23872534
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction between sterol regulatory element-binding protein-1c, nuclear factor Y, and 3,5,3'-triiodothyronine nuclear receptors.
Jump DB; Thelen AP; Mater MK
J Biol Chem; 2001 Sep; 276(37):34419-27. PubMed ID: 11448969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
